Literature DB >> 8721225

Immunization against Trichinella spiralis using antigens from different life-cycle stages experimental study in mice.

R A Darwish1, M M Sanad, S M Youssef.   

Abstract

Crude antigen preparations from different life-cycle stages of T. spiralis using 10 micrograms and 100 micrograms antigen/dose, were tested for their ability to immunize mice against homologous challenge infection. Immunization was assessed by accelerated expulsion of adult worms, reduction in female worm fecundity and decreased yield of muscle larvae. The dose of 100 micrograms proved to be more protective in all antigen preparations. The AA provided highly significant protection against adult stages (89%) and muscle larvae (80%). NLA produced highly significant protection against muscle larvae only (76%). MLA provided highly significant protection against adult stages (74%), female fecundity (74%) and muscle larvae (80%). Combination of AA and MLA produced highly significant protection against adult stages (96%), female fecundity (73%) and muscle larvae (86). The results show that all antigen preparations provided variable, considerable but partial protection against challenge infection. The variations in immunization potential are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8721225

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  2 in total

1.  Oral vaccination with Trichinella spiralis DNase II DNA vaccine delivered by attenuated Salmonella induces a protective immunity in BALB/c mice.

Authors:  Xin Qi; Yue Han; Peng Jiang; Xin Yue; Hua Nan Ren; Ge Ge Sun; Shao Rong Long; Chuan Yu; Xiang Chao Cheng; Jing Cui; Zhong Quan Wang
Journal:  Vet Res       Date:  2018-12-05       Impact factor: 3.683

Review 2.  Vaccines as a Strategy to Control Trichinellosis.

Authors:  Bin Tang; Jian Li; Tingting Li; Yiting Xie; Wei Guan; Yanqing Zhao; Shuguo Yang; Mingyuan Liu; Daoxiu Xu
Journal:  Front Microbiol       Date:  2022-03-23       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.